PMID:18084243: Difference between revisions
Jump to navigation
Jump to search
Update TableEdit tables. |
/Volumes/r3/t3/ul/working/touchTables/touch_all_tables.php |
||
| Line 26: | Line 26: | ||
****************************************************************************************** --> | ****************************************************************************************** --> | ||
{| id="Y47ab4578bf576" class=" tableEdit GO_table_reference" | {| id="Y47ab4578bf576" class=" tableEdit GO_table_reference" | ||
|- | |- {{table heading style}} | ||
!|Gene product!!Qualifier!!GO ID!!GO term name!!Evidence Code!!with/from!!Aspect!!Notes!!Status | !|Gene product!!Qualifier!!GO ID!!GO term name!!Evidence Code!!with/from!!Aspect!!Notes!!Status | ||
Revision as of 20:39, 17 June 2010
Fensterle, J, Bergmann, B, Yone, CL, Hotz, C, Meyer, SR, Spreng, S, Goebel, W, Rapp, UR and Gentschev, I (2008) Cancer immunotherapy based on recombinant Salmonella enterica serovar Typhimurium aroA strains secreting prostate-specific antigen and cholera toxin subunit B.Cancer Gene Ther. 15:85-93
| Abstract | Prostate cancer is the most common malignant tumor in men and is normally associated with increased serum levels of prostate-specific antigen (PSA). Therefore, PSA is one potential target for a prostate cancer vaccine. In this study we analyzed the functionality of new bacterial PSA vaccines, expressed and secreted via the hemolysin (HlyA) secretion system of Escherichia coli, the prototype of Type I secretion systems (T1SS) using an attenuated Salmonella enterica serovar Typhimurium aroA strain as carrier. The data demonstrate that a bacterial live vaccine encompassing T1SS in combination with cholera toxin subunit B can be successfully used for delivery of PSA to induce cytotoxic CD8+ T-cell responses resulting in an efficient prevention of tumor growth in mice. |
| Links | PubMed |
Significance
You can help EcoliWiki by summarizing why this paper is useful
Useful Materials and Methods
You can help Ecoliwiki by describing the useful materials (strains, plasmids, antibodies, etc) described in this paper.
Annotations
| Gene product | Qualifier | GO ID | GO term name | Evidence Code | with/from | Aspect | Notes | Status |
|---|---|---|---|---|---|---|---|---|
| edit table |
EcoliWiki Links
Add links to pages that link here (e.g. gene, product, method pages)
References
See Help:References for how to manage references in EcoliWiki.